Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China
- PMID: 29924052
- PMCID: PMC6023650
- DOI: 10.1097/MD.0000000000011219
Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China
Abstract
Because the epidemiology of Clostridium difficile infection (CDI) is region-specific, the present study was undertaken to examine the epidemiology of C difficile outbreaks in Beijing, China.Eighty nonduplicate isolates were collected from March, 2016 to December, 2016. The molecular type and phylogenetic analysis were evaluated by multilocus sequence typing (MLST). The minimum inhibitory concentrations (MICs) for 11 antibiotics and the resistance mechanisms were investigated.Sixty-five toxigenic strains (81.25%), including 22 tcdABCDT strains (27.5%) and 43 tcdABCDT strains (53.75%), and also 15 nontoxigenic strains (tcdABCDT; 18.75%) were detected. MLST identified 21 different sequence types (STs), including 2 novel types (ST409 and ST416). All isolates were susceptible to metronidazole, vancomycin, fidaxomicin, piperacillin/tazobactam, and meropenem, and all were effectively inhibited by emodin (MICs 4-8 μg/mL). The resistance rates to rifaximin, ceftriaxone, clindamycin, erythromycin, and ciprofloxacin were 8.75%, 51.25%, 96.25%, 81.25%, and 96.25%, respectively; 81.25% (65/80) of isolates were multidrug-resistant. Amino acid mutations in GyrA and/or GyrB conferred quinolone resistance. One novel amino acid substitution, F86Y in GyrA, was found in 1 CIP-intermediate strain. The erm(B) gene played a key role in mediating macrolide-lincosamide-streptogramin B (MLSB) resistance. Erm(G) was also found in erm(B)-negative strains that were resistant to both erythromycin and clindamycin. RpoB mutations were associated with rifampin resistance, and 2 new amino mutations were identified in 1 intermediate strain (E573A and E603N).Regional diversity and gene heterogeneity exist in both the ST type and resistant patterns of clinical C difficile isolates in Northern China.
Figures
Similar articles
-
The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.Int J Antimicrob Agents. 2020 Jul;56(1):105981. doi: 10.1016/j.ijantimicag.2020.105981. Epub 2020 Apr 21. Int J Antimicrob Agents. 2020. PMID: 32330584
-
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China.J Med Microbiol. 2018 Jan;67(1):52-59. doi: 10.1099/jmm.0.000646. Epub 2017 Nov 21. J Med Microbiol. 2018. PMID: 29160203
-
Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.Microbiol Spectr. 2022 Feb 23;10(1):e0132221. doi: 10.1128/spectrum.01322-21. Epub 2022 Jan 12. Microbiol Spectr. 2022. PMID: 35019676 Free PMC article.
-
Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.Antimicrob Resist Infect Control. 2020 Sep 25;9(1):158. doi: 10.1186/s13756-020-00815-5. Antimicrob Resist Infect Control. 2020. PMID: 32977835 Free PMC article.
-
A narrative review of Clostridioides difficile infection in China.Anaerobe. 2022 Apr;74:102540. doi: 10.1016/j.anaerobe.2022.102540. Epub 2022 Feb 24. Anaerobe. 2022. PMID: 35219837 Review.
Cited by
-
Genomic study of European Clostridioides difficile ribotype 002/sequence type 8.Microb Genom. 2024 Jul;10(7):001270. doi: 10.1099/mgen.0.001270. Microb Genom. 2024. PMID: 39051872 Free PMC article.
-
Clostridium difficile in Asia: Opportunities for One Health Management.Trop Med Infect Dis. 2018 Dec 28;4(1):7. doi: 10.3390/tropicalmed4010007. Trop Med Infect Dis. 2018. PMID: 30597880 Free PMC article. Review.
-
Update on Commonly Used Molecular Typing Methods for Clostridioides difficile.Microorganisms. 2023 Jul 5;11(7):1752. doi: 10.3390/microorganisms11071752. Microorganisms. 2023. PMID: 37512924 Free PMC article. Review.
-
Colonization of Toxigenic Clostridium difficile Among Intensive Care Unit Patients: A Multi-Centre Cross-Sectional Study.Front Cell Infect Microbiol. 2020 Jan 30;10:12. doi: 10.3389/fcimb.2020.00012. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32083021 Free PMC article.
-
Antibiotic Resistance Profile of RT 027/176 Versus Other Clostridioides difficile Isolates in Silesia, Southern Poland.Pathogens. 2022 Aug 22;11(8):949. doi: 10.3390/pathogens11080949. Pathogens. 2022. PMID: 36015069 Free PMC article.
References
-
- Elliott B, Androga GO, Knight DR, et al. Clostridium difficile infection: evolution, phylogeny and molecular epidemiology. Infect Genet Evol 2017;49:1–1. - PubMed
-
- To KB, Napolitano LM. Clostridium difficile infection: update on diagnosis, epidemiology, and treatment strategies. Surg Infect 2014;15:490–502. - PubMed
-
- Miller BA, Chen LF, Sexton DJ, et al. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 2011;32:387–90. - PubMed
-
- Owens RC, Jr, Donskey CJ, Gaynes RP, et al. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008;46:S19–31. - PubMed
-
- Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011;365:1693–703. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases